Denmark
· Delayed Price · Currency is DKK ViroGates Statistics
Total Valuation
ViroGates has a market cap or net worth of DKK 50.27 million. The enterprise value is 44.35 million.
| Market Cap | 50.27M |
| Enterprise Value | 44.35M |
Important Dates
The last earnings date was Thursday, May 1, 2025.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ViroGates has 7.73 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 7.73M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 36.61% |
| Owned by Institutions (%) | n/a |
| Float | 4.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.38 |
| PB Ratio | 6.28 |
| P/TBV Ratio | 6.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.28 |
| EV / Sales | 6.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.24, with a Debt / Equity ratio of 0.66.
| Current Ratio | 4.24 |
| Quick Ratio | 3.60 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.02 |
Financial Efficiency
Return on equity (ROE) is -126.35% and return on invested capital (ROIC) is -53.10%.
| Return on Equity (ROE) | -126.35% |
| Return on Assets (ROA) | -46.98% |
| Return on Invested Capital (ROIC) | -53.10% |
| Return on Capital Employed (ROCE) | -110.75% |
| Revenue Per Employee | 680,800 |
| Profits Per Employee | -1.35M |
| Employee Count | 10 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 0.78 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.46% in the last 52 weeks. The beta is 1.09, so ViroGates's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -1.46% |
| 50-Day Moving Average | 7.63 |
| 200-Day Moving Average | 9.06 |
| Relative Strength Index (RSI) | 45.08 |
| Average Volume (20 Days) | 3,799 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ViroGates had revenue of DKK 6.81 million and -13.53 million in losses.
| Revenue | 6.81M |
| Gross Profit | 4.14M |
| Operating Income | -13.60M |
| Pretax Income | -14.32M |
| Net Income | -13.53M |
| EBITDA | n/a |
| EBIT | -13.60M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 11.23 million in cash and 5.30 million in debt, giving a net cash position of 5.93 million or 0.77 per share.
| Cash & Cash Equivalents | 11.23M |
| Total Debt | 5.30M |
| Net Cash | 5.93M |
| Net Cash Per Share | 0.77 |
| Equity (Book Value) | 8.01M |
| Book Value Per Share | n/a |
| Working Capital | 12.10M |
Cash Flow
| Operating Cash Flow | -9.13M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 60.74%, with operating and profit margins of -199.82% and -198.78%.
| Gross Margin | 60.74% |
| Operating Margin | -199.82% |
| Pretax Margin | -210.33% |
| Profit Margin | -198.78% |
| EBITDA Margin | n/a |
| EBIT Margin | -199.82% |
| FCF Margin | n/a |
Dividends & Yields
ViroGates does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -26.92% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |